Horizon Techn Stock Price, News & Analysis

Horizon Technology Finance (NASDAQ: HRZN), a specialty finance company providing secured loans to venture capital-backed companies, has scheduled its first quarter 2025 financial results announcement for April 29, 2025, after market close.

The company will host a conference call on April 30, 2025, at 9:00 a.m. ET to discuss the results. Key executives including CEO Robert D. Pomeroy, Jr., President Gerald A. Michaud, COO/CIO Daniel S. Devorsetz, and CFO Daniel R. Trolio will participate in the call.

Investors can join via phone at (877) 407-9716 (domestic) or (201) 493-6779 (international) using conference ID 13752635, or through a live webcast on the company's website. The webcast recording will be available for 30 days following the call.

Horizon Technology Finance (NASDAQ: HRZN) reported strong Q1 2025 performance with $100.3 million in new loan originations and $2.0 million in equity investments. The company's venture debt portfolio grew for the third consecutive quarter, while maintaining a robust committed backlog of $235.5 million across 19 companies.

Notable Q1 achievements include $68.1 million in loan payoffs generating accelerated income and prepayment fees. The company funded diverse sectors including gene therapy, oncology research, agricultural technology, and healthcare solutions. HRZN closed $121.8 million in new loan commitments to seven companies, up from $80.2 million in Q4 2024.

The company maintains a portfolio of warrant and equity positions in 105 portfolio companies, including 93 private companies, positioning itself for potential future returns. Regular principal payments received totaled $11.2 million during the quarter.

Horizon Technology Finance (NASDAQ: HRZN) has declared monthly cash distributions of $0.11 per share for April, May, and June 2025, totaling $0.33 per share. The company, a specialty finance provider affiliated with Monroe Capital, offers secured loans to venture capital-backed companies in technology, life science, healthcare information services, and sustainability sectors.

Since its IPO in 2010, Horizon has distributed a total of $304 million to shareholders. The company maintains a Dividend Reinvestment Plan (DRIP) allowing automatic reinvestment of distributions into additional shares unless stockholders opt out. DRIP shares can be issued as new stock or purchased from the open market, with valuation based on closing prices or average purchase prices respectively.

Horizon Technology Finance (NASDAQ: HRZN) has released its Q4 and full-year 2024 financial results. The company reported Q4 net investment income (NII) of $10.4 million ($0.27 per share), down from $15.0 million ($0.45 per share) in the prior-year period. The total investment portfolio reached $697.9 million with a debt portfolio yield of 14.9%.

Key Q4 metrics include NAV of $336.2 million ($8.43 per share), funding of seven loans totaling $59.1 million, and raising $18.8 million through ATM offerings. The company maintained strong liquidity with $100.9 million in cash and $244.0 million in credit facility capacity.

For full-year 2024, NII was $47.8 million ($1.32 per share), compared to $61.4 million ($1.98 per share) in 2023. The company funded 25 loans totaling $197.2 million and achieved an annual portfolio yield of 15.6%. HRZN has declared regular monthly distributions of $0.11 per share through June 2025.

Horizon Technology Finance (NASDAQ: HRZN), a specialty finance company providing secured loans to venture capital-backed companies, announced it will release its fourth quarter 2024 financial results on Tuesday, March 4, 2025, after market close.

The company has scheduled a conference call to discuss the results on Wednesday, March 5, 2025, at 9:00 a.m. ET. The call will feature remarks from key executives including the CEO, President, COO/CIO, and CFO. Participants can join via phone or through a live webcast on the company's website, which will remain available for 30 days following the call.

Horizon Technology Finance (NASDAQ: HRZN) reported strong Q4 2024 performance, originating $59.1 million in new loans and $1.9 million in equity investments. The company expanded its venture debt portfolio for the second consecutive quarter and increased its committed backlog to $206.5 million.

Key Q4 highlights include funding to several new portfolio companies: $30.0 million to Onkos Surgical, $15.0 million to Crafty Holdings, $5.0 million each to OneNetwork and Ursa Space Systems. The quarter saw liquidity events from five portfolio companies, with principal prepayments totaling $13.0 million, compared to $37.5 million in Q3 2024.

HRZN received $12.2 million in regularly scheduled principal payments and closed new loan commitments of $80.2 million to six companies. The company maintains a portfolio of warrant and equity positions in 103 portfolio companies, including 91 private companies.

Horizon Technology Finance (NASDAQ: HRZN) has provided a $35 million venture loan facility to Onkos Surgical, with $30 million initially funded. The funding will accelerate manufacturing and commercialization of NanoCept™, an FDA-granted antibacterial coating technology for orthopedic implants.

NanoCept received the first-ever FDA De Novo authorization for an antibacterial coating technology on orthopedic implants in April 2024. The technology has demonstrated up to 99.999% kill rate in standardized in-vitro testing of common operating room bacteria. Onkos Surgical, backed by investors including 1315 Capital, Canaan Partners, and SV Health Investors, operates in a $3 billion market developing solutions for adult and pediatric patients with bone loss from tumor, trauma, or failed orthopedic implant revision.

Horizon Technology Finance (NASDAQ: HRZN) has provided a $10 million venture loan facility to Finexio, with $5 million initially funded. Finexio, backed by JP Morgan and Mendon Venture Partners, is a B2B payments company offering AI-powered 'Accounts Payable Payments as a Service'. The platform automates and digitizes payments through various methods including ACH, virtual credit cards, and checks, integrating with existing AP and Procurement systems.

The loan proceeds will be used for general growth and working capital purposes. Finexio's platform utilizes predictive analytics to optimize payment timing and cash flow while providing fraud prevention capabilities.

Horizon Technology Finance has provided a $10 million venture loan facility to Ursa Space Systems, a leading satellite intelligence company. Ursa Space serves government and commercial clients worldwide through an extensive virtual network of over 200 satellites, combining Synthetic Aperture Radar, Electro-Optical, and Radio Frequency data with AI-enabled processing. The company, backed by investors including Dorilton Capital, RRE Ventures, and Paladin Capital Group, will use the loan proceeds for general growth and working capital purposes. Ursa Space's platform provides access to over 55 million satellite images and delivers critical intelligence through custom solutions and subscription services.